CD4+ helper T cells are critical regulators in immunity and inflammation. Growing evidence has indicated their involvement in cancer, by shaping the tumor microenvironment. In this study, I summarize latest literature on Th2 and Th17 cells in cancer-associated inflammation and propose that they may be targeted for cancer immunotherapy.
Get full access to this article
View all access options for this article.
References
1.
ChangSH, MirabolfathinejadSG, KattaH, CumpianAM, GongL, CaetanoMS, MoghaddamSJ, DongC. 2014. T helper 17 cells play a critical pathogenic role in lung cancer. Proc Natl Acad Sci U S A, 111(15):5664–5669.
HaghshenasMR, KhademiB, FaghihZ, GhaderiA, ErfaniN. 2015. Immune regulatory cells and IL17-producing lymphocytes in patients with benign and malignant salivary gland tumors. Immunol Lett, 164(2):109–116.
11.
JiangZ, ChenJ, DuX, ChengH, WangX, DongC. 2016. IL-25 blockade inhibits metastasis in breast cancer. Protein Cell, 8(3):191–201.
12.
KohrtHE, NouriN, NowelsK, JohnsonD, HolmesS, LeePP. 2005. Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer. PLoS Med, 2(9):e284.
13.
KryczekI, BanerjeeM, ChengP, VatanL, SzeligaW, WeiS, HuangE, FinlaysonE, SimeoneD, WellingTH, ChangA, CoukosG, LiuR, ZouW. 2009a. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood, 114(6):1141–1149.
14.
KryczekI, WeiS, SzeligaW, VatanL, ZouW. 2009b. Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood, 114(2):357–359.
15.
LaiY, DongC. 2015. Therapeutic antibodies that target inflammatory cytokines in autoimmune diseases. Int Immunol, 28(4):181–188.
Martin-OrozcoN, MuranskiP, ChungY, YangXO, YamazakiT, LuS, HwuP, RestifoNP, OverwijkWW, DongC. 2009. T Helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity, 31(5):787–798.
19.
Pedroza-GonzalezA, XuK, WuTC, AspordC, TindleS, MarchesF, GallegosM, BurtonEC, SavinoD, HoriT, TanakaY, ZurawskiS, ZurawskiG, BoverL, LiuYJ, BanchereauJ, PaluckaAK. 2011. Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation. J Exp Med, 208(3):479–490.
20.
PuntS, DronkersEAC, WeltersMJP, GoedemansR, KoljenovićS, BloemenaE, SnijdersPJF, GorterA, van der BurgSH, de JongRJB, JordanovaES. 2016. A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17+ cell frequency. Cancer Immunol Immunother, 65(4):393–403.
21.
TodoricJ, AntonucciL, KarinM. 2016. Targeting inflammation in cancer prevention and therapy. Cancer Prev Res, 9(12):895–905.
22.
TongZ, YangXO, YanH, LiuW, NiuX, ShiY, FangW, XiongB, WanY, DongC. 2012. A protective role by interleukin-17F in colon tumorigenesis. PLoS One, 7(4):e34959.
